首页> 外文期刊>国际眼科杂志:英文版 >Preliminary studies of constructing a tissue-engineered lamellar corneal graft by culturing mesenchymal stem cells onto decellularized corneal matrix
【24h】

Preliminary studies of constructing a tissue-engineered lamellar corneal graft by culturing mesenchymal stem cells onto decellularized corneal matrix

机译:通过培养间充质干细胞构建组织工程层状拐角移植物在脱细胞化角膜基质中构建组织工程层状膜接枝的初步研究

获取原文
获取原文并翻译 | 示例
       

摘要

AIM:To construct a competent corneal lamellar substitute in order to alleviate the shortage of human corneal donor.METHODS:Rabbit mesenchymal stem cells(MSCs)were isolated from bone marrow and identified by flow cytometric,osteogenic and adipogenic induction.Xenogenic decellularized corneal matrix(XDCM)was generated from dog corneas.MSCs were seeded and cultured on XDCM to construct the tissueengineered cornea.Post-transplantation biocompatibility of engineered corneal graft were tested by animal experiment.Rabbits were divided into two groups then underwent lamellar keratoplasty(LK)with different corneal grafts:1)XDCM group(n=5):XDCM;2)XDCM-MSCs groups(n=4):tissue-engineered cornea made up with XDCM and MSCs.The ocular surface recovery procedure was observed while corneal transparency,neovascularization and epithelium defection were measured and compared.In vivo on focal exam was performed 3 mo postoperatively.RESULTS:Rabbit MSCs were isolated and identified.Flow cytometry demonstrated isolated cells were CD90 positive and CD34,CD45 negative.Osteogenic and adipogenic induction verified their multipotent abilities.MSC-XDCM grafts were constructed and observed.In vivo transplantation showed the neovascularization in XDCMMSC group was much less than that in XDCM group postoperatively.Post-transplant 3-month confocal test showed less nerve regeneration and bigger cell-absent area in XDCM-MSC group.CONCLUSION:This study present a novel corneal tissue-engineered graft that could reduce post-operatively neovascularization and remain transparency,meanwhile shows that co-transplantation of MSCs may help increase corneal transplantation successful rate and enlarge the source range of corneal substitute to overcome cornea donor shortage.
机译:目的:构建一个态度的角膜层层替代品,以缓解人角膜供体的短缺。方法:兔间充质干细胞(MSCs)与骨髓分离,并通过流式细胞术,骨质发生和脂肪诱导的鉴定。钠脱细胞内膜基质( XDCM)由狗玉米体产生,在XDCM上培养并培养以构建疾病角膜。通过动物实验测试了工程角膜移植物的移栽生物相容性。将其分为两组,然后分为两组,然后用不同的层状角色成形术(LK)。随后分为两组角膜移植物:1)XDCM组(n = 5):XDCM; 2)XDCM-MSCS组(n = 4):组织工程角膜与XDCM和MSCs组成。观察眼部表面恢复程序,而角膜透明度,新血管化测量并进行上皮缺陷并进行比较。在术后3Mo进行局灶性检查的体内。结果:兔MSCs被隔离并鉴定。流量表明D分离的细胞是CD90阳性和CD34,CD45阴性。睾丸和脂肪诱导验证了它们的多能力能力。构建和观察到它们的多能力。在XDCMMSC组中,体内移植术后,XDCM组在XDCM集团中的新血管形成.POST - 植物3个月的共焦试验显示XDCM-MSC组中的神经再生和更大的细胞缺陷区域。结论:本研究表明了一种新的角膜组织工程移植物,其可以减少可操作性的新血管化并保持透明度,同时显示有限公司 - MSCs的改移可能有助于增加角膜移植成功率并扩大角膜替代品的源范围,以克服角膜捐助者短缺。

著录项

  • 来源
    《国际眼科杂志:英文版》 |2021年第1期|P.10-18|共9页
  • 作者单位

    Department of Ophthalmology Peking University Third Hospital Beijing 100191 ChinaBeijing Key Laboratory of Restoration of Damaged Ocular Nerve Peking University Third Hospital Beijing 100191 China;

    Department of Ophthalmology Peking University Third Hospital Beijing 100191 ChinaBeijing Key Laboratory of Restoration of Damaged Ocular Nerve Peking University Third Hospital Beijing 100191 China;

    Department of Ophthalmology Peking University Third Hospital Beijing 100191 ChinaBeijing Key Laboratory of Restoration of Damaged Ocular Nerve Peking University Third Hospital Beijing 100191 China;

    Department of Ophthalmology Peking University Third Hospital Beijing 100191 ChinaBeijing Key Laboratory of Restoration of Damaged Ocular Nerve Peking University Third Hospital Beijing 100191 China;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 chi
  • 中图分类 人体形态学;
  • 关键词

    mesenchymal stem cells; xenogenic decellularized corneal matrix; acellular corneal matrix; neovascularization; tissue-engineered cornea;

    机译:间充质干细胞;异叶脱细胞角膜基质;细胞角膜基质;新生血管;组织工程角膜;
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号